NEW YORK (GenomeWeb News) – Idaho Technology has won a $3.6 million grant from the National Institutes of Health to continue developing a point-of-care molecular diagnostic platform geared for use particularly in underserved populations such as rural communities and the urban poor.
The Point-of-Care FilmArray that the company is developing will test for multiple viral and bacterial targets, such as respiratory pathogens, sepsis, and sexually transmitted infections, and will deliver results in less than an hour.